Search Results

Heart Hospital of New Mexico at Lovelace Medical Center and GE HealthCare announced HHNM as the first location in the United States to install GE HealthCare’s latest Allia Image Guided System Pulse, which was designed to provide exceptional image quality and improve workflow for the diagnosis and treatment of cardiovascular diseases.

BioCryst Pharmaceuticals, Inc. announced that the Federal Commission for Protection against Health Risks in Mexico has granted approval for oral, once-daily ORLADEYO® for the prophylaxis of hereditary angioedema attacks in adults and pediatric patients 12 years of age or older.

The Chemours Company, a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, announced that the Mexican government has lifted its prior water intake restrictions, enabling the Company to resume normal operations at its titanium dioxide manufacturing facility in Altamira, Mexico.

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced the addition of a new Universal Plus Panel to its Foresight® Carrier Screen.

ACG Engineering, a division of ACG, the world’s only integrated pharmaceutical solutions and manufacturing company

The Comisión Federal para la Protección contra Riesgos Sanitarios has approved CTL Amedica Corporation’s MONET™ Anterior Cervical Interbody Fusion System for use in Mexico.

Simulations Plus, Inc. today announced that, through a joint proposal with the University of Bath’s Department of Life Sciences and other university partners, it has been awarded a new funded grant from the U.S. Food and Drug Administration (FDA).

A new observational study from the University of Iowa points to the potential of alpha-blocker drugs, commonly used to treat enlarged prostates, as a preventive therapeutic option for dementia with Lewy bodies.